SPRINGFIELD HOUSE — All Prescriptions & Medications — Page 2
Practice Code: P85020 | OLDHAM, OL4 2RJ
Showing results 51-100 of 541
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Empagliflozin | 837 | 24.2K | £30.1K | +33.7% ▲ |
| Atenolol | 834 | 26.5K | £582 | +38.3% ▲ |
| Montelukast | 818 | 21.9K | £1.1K | +19.5% ▲ |
| Diazepam | 786 | 23.0K | £618 | +57.8% ▲ |
| Senna | 781 | 40.7K | £919 | +29.8% ▲ |
| Hydrocortisone | 760 | 25.7K | £4.2K | +69.5% ▲ |
| Lamotrigine | 755 | 47.9K | £4.4K | +27.8% ▲ |
| Carbocisteine | 744 | 135.7K | £3.4K | +39.4% ▲ |
| Dapagliflozin | 741 | 20.8K | £25.9K | -40.8% ▼ |
| Fluticasone/umeclidinium/vilanterol | 723 | 723 | £30.6K | +208.4% ▲ |
| Memantine hydrochloride | 708 | 27.5K | £2.7K | +114.3% ▲ |
| Alginic acid compound preparations | 704 | 360.9K | £5.9K | +20.2% ▲ |
| Fluoxetine hydrochloride | 699 | 25.1K | £997 | -31.1% ▼ |
| Venlafaxine | 698 | 24.1K | £4.2K | -17.4% ▼ |
| Latanoprost | 697 | 9,110 | £3.4K | +43.6% ▲ |
| Influenza | 689 | 689 | £8.3K | -56.1% ▼ |
| 678 | 83.1K | £4.3K | +42.9% ▲ | |
| 666 | 374.2K | £4.7K | -32.3% ▼ | |
| Sodium valproate | 663 | 81.6K | £9.7K | +108.4% ▲ |
| Levetiracetam | 652 | 47.3K | £3.9K | +42.4% ▲ |
| Esomeprazole | 651 | 25.9K | £1.5K | +60.9% ▲ |
| Ferrous sulfate | 618 | 33.4K | £1.1K | +20.2% ▲ |
| Doxycycline hyclate | 616 | 6,216 | £615 | +20.2% ▲ |
| Solifenacin | 605 | 18.9K | £729 | +26.8% ▲ |
| Rosuvastatin calcium | 602 | 17.7K | £554 | -32.9% ▼ |
| Buprenorphine | 593 | 2,379 | £10.7K | +61.9% ▲ |
| Promethazine hydrochloride | 592 | 16.8K | £1.9K | +65.6% ▲ |
| Lercanidipine hydrochloride | 581 | 17.2K | £1.9K | -5.9% ▼ |
| Edoxaban | 574 | 16.2K | £27.0K | -18.1% ▼ |
| Codeine phosphate | 573 | 36.9K | £1.4K | -20.3% ▼ |
| 562 | 340.5K | £4.7K | +113.0% ▲ | |
| Fluticasone furoate/vilanterol | 552 | 558 | £12.6K | +256.5% ▲ |
| Finasteride | 546 | 15.7K | £560 | -16.6% ▼ |
| 544 | 1,120 | £38.1K | -0.2% vs avg | |
| Tiotropium bromide | 542 | 3,620 | £12.9K | +78.3% ▲ |
| Eplerenone | 539 | 13.7K | £1.7K | +103.3% ▲ |
| Trazodone hydrochloride | 537 | 24.0K | £1.2K | +162.7% ▲ |
| Famotidine | 515 | 19.0K | £11.3K | +5.5% ▲ |
| Ezetimibe | 497 | 12.8K | £2.3K | -30.1% ▼ |
| Irbesartan | 496 | 14.8K | £629 | +103.6% ▲ |
| Alogliptin | 496 | 14.6K | £13.2K | +95.6% ▲ |
| Insulin aspart | 491 | 2,554 | £16.2K | +28.9% ▲ |
| Mirabegron | 484 | 13.4K | £12.4K | +20.5% ▲ |
| 470 | 6,498 | £4.2K | -29.3% ▼ | |
| Sildenafil (Erectile Dysfunction) | 466 | 3,546 | £1.2K | -7.5% ▼ |
| Quetiapine | 456 | 21.0K | £5.1K | -26.8% ▼ |
| Cetirizine hydrochloride | 450 | 29.1K | £1.5K | -9.9% ▼ |
| Nitrofurantoin | 430 | 5,308 | £3.6K | -9.9% ▼ |
| Insulin glargine | 426 | 1,806 | £14.4K | +50.0% ▲ |
| Flucloxacillin sodium | 425 | 20.4K | £1.0K | -5.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.